Signal Diagnosticsは、虚偽の請求法に関する告訴を解決するために20.5百万ドルを支払うことに同意しました。
Signal Diagnostics LLCは、HRSAの未保険者プログラムへの過払い金を保持したとして偽装請求法を違反したとされる訴訟を解決するために2050万ドルを支払うことに同意しました。
なぜ重要か. この調達はシグナル診断に影響を与え、医療規制の遵守のリスクを浮き彫りにし、会社の財務状態と評判に影響を及ぼしています。
01
誰に影響するか
- 1Signal Diagnostics LLC
- の規制対象 →事実
02
根拠
- UUS Department of Justice press規制当局2026-09-30 20:00
Signal Diagnostics LLC (Signal) has agreed to pay the United States $20.5 million to resolve allegations that Signal violated the False Claims Act by knowingly retaining and improperly avoiding its obligations to repay the Health Resources & Services Administration (HRSA) COVID-19 Claims Reimbursement to Health Care
- UUS Department of Justice press規制当局2026-09-30 20:00
Signal Diagnostics LLC (Signal) has agreed to pay the United States $20.5 million to resolve allegations that Signal violated the False Claims Act by knowingly retaining and improperly avoiding its obligations to repay the Health Resources & Services Administration (HRSA) COVID-19 Claims Reimbursement to Health Care Providers and Facilities for Testing, Treatment, and Vaccine Administration for t…
- UUS Department of Justice press規制当局2026-09-30 20:00
Independence Blue Cross (IBX), an insurance company incorporated under the laws of Pennsylvania, has agreed to pay $22.5 million to resolve allegations that it violated the False Claims Act by...